Skip to main content

FDA cuts gap for Moderna COVID-19 booster dose as cases surge

The Food and Drug Administration on Friday shortened the interval between the primary series of Moderna's COVID-19 vaccine and a booster dose to five months, as it looks to bolster protection against the fast-spreading omicron variant.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.